Literature DB >> 7485112

Sustained granulocyte recovery after G-CSF in a patient with ticlopidine-induced severe aplastic anemia.

K Arribalzaga, J García-Suárez, M López-Rubio, I Krsnik, M A Calero, J F Del Campo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7485112     DOI: 10.1002/ajh.2830500419

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  2 in total

1.  Hematologic dyscrasia associated with ticlopidine therapy: evidence for causality.

Authors:  F L Paradiso-Hardy; C M Angelo; K L Lanctôt; E A Cohen
Journal:  CMAJ       Date:  2000-11-28       Impact factor: 8.262

Review 2.  Adverse haematological effects of ticlopidine. Prevention, recognition and management.

Authors:  B B Love; J Biller; M Gent
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.